SCHEMBL6228472

SCHEMBL6228472

[2H]C1=CC2=CC3=NC(=CC4=NC(=CC5=NC(=CC1=N2)C=C5)C=C4)C=C3.[GaH3]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6227562 0.98 — —
SCHEMBL1603253 0.95 — —
SCHEMBL1603263 0.95 — —
SCHEMBL1603252 0.95 — —
SCHEMBL1603047 0.95 — —
SCHEMBL1603317 0.95 — —
SCHEMBL1602933 0.95 — —
SCHEMBL1603958 0.95 — —
SCHEMBL1603345 0.95 — —
Iodide SCHEMBL6227142 0.95 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1450790-A4 PHOTOSENSITIZING CARBAMATE DERIVATIVES MIRAVANT PHARM INC (US) 2005-10-26 — — EP disclosed
EP-1401506-A4 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY MIRAVANT PHARM INC (US) 2005-02-16 — — EP disclosed
US-20040266748-A1 Photosensitizing carbamate derivatives MIRAVANT PHARMACEUTICALS, INC. 2004-12-30 — — US disclosed
EP-1450790-A2 PHOTOSENSITIZING CARBAMATE DERIVATIVES Miravant Pharmaceuticals, Inc. (US) 2004-09-01 — — EP disclosed
EP-1401506-A2 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY Miravant Pharmaceuticals, Inc. (US) 2004-03-31 — — EP disclosed
WO-2003028628-A2 PHOTOSENSITIZING CARBAMATE DERIVATIVES MIRAVANT PHARMACEUTICALS, INC. (US) 2003-04-10 — — WO disclosed
WO-2002096366-A2 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY MIRAVANT PHARMACEUTICALS, INC. (US) 2002-12-05 — — WO disclosed
Send feedback